Scientists rely on a wide array of cells as experimental models for research
In vitro human cell line models have been widely used for applications such as toxicology, immunology, and cancer pharmacogenomic studies to predict therapeutic efficacy and to identify novel mechanisms associated with variation in drug response. ATCC advanced cell models such as luciferase-labeled cells, isogenic cells, neural progenitor cells, solute transporter carrier cells, and next-generation cell models will ensure your research results are reproducible and verifiable.
Cell models
HCMI cell models
We are continually adding 2-D and 3-D patient-derived cancer models to our portfolio. These next-generation models include both common as well as rare and understudied examples of cancer from numerous tissues.
Immuno-oncology models
Explore our checkpoint luciferase reporter cells, CAR-T target luciferase reporter cells, THP-1 reporter cells, and primary immune cells that support the development of immuno-oncology therapies.
Neural Progenitor Cells
Neural Progenitor Cell (NPC) solutions from ATCC are potent models of normal and disease neurobiology and important tools for investigating neural development, degeneration and regeneration, neurogenetics, neural excitability, nervous system disorders, neurotransmitters, neurotoxicity, and drug screening.
More NPC InfoSolute Transporter Carrier Cells
There is growing demand for in vitro kidney transporter models with normal human renal function. By using well-characterized hTERT-immortalized RPTEC's that stably overexpress the OAT1, OCT2, or OAT3 gene, ATCC created kidney cell models that provide renal tissue-relevant results and predictability for clinical trials.
Find Out More
